Clinical Trial of the Use of Ketamine in Treatment Resistant Depression
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the efficacy of the use of intravenous low-dose
ketamine in the treatment of treatment-resistant depression (TRD), as well as the changes in
Glutamate neurotransmission and inflammatory serum markers.
Phase:
Phase 4
Details
Lead Sponsor:
National Institute of Neurology and Neurosurgery, Mexico